Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRISTINE: Personalised Medicine for Children with Asthma
NCT03269318Phase 4Terminated
- Sponsor
- Brighton and Sussex University Hospitals NHS Trust
- Start
- Jul 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of salmeterol and montelukast in asthma (2 arms), sponsored by Brighton and Sussex University Hospitals NHS Trust. Primary endpoints: Willingness to be recruited and randomised, Retention issues and reasons and 2 more. Started Jul 2017; status: terminated.
02
Drugs
salmeterolmontelukast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03269318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03269318.